Company Filing History:
Years Active: 2003-2005
Title: David M Oakley: Innovator in Pharmaceutical Formulations
Introduction
David M Oakley is an accomplished inventor based in the United States. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of extended-release medications. His innovative approach focuses on creating formulations that enhance the delivery and effectiveness of various drug substances.
Latest Patents
David M Oakley currently holds a patent for "Extended-Release Pharmaceutical Formulations." This invention provides matrix-forming, sustained-release pharmaceutical formulations comprising four primary components: i) an effective amount of at least one drug substance; ii) at least one pharmaceutically acceptable, water-swellable, pH independent polymer; iii) at least one pharmaceutically-acceptable, anionic, pH dependent polymer; and iv) a pharmaceutically-acceptable polymer selected from the group consisting of a) at least one pharmaceutically-acceptable cationic polymer; and b) at least one pharmaceutically acceptable hydrocolloid. The present formulations can be used with compounds having a wide range of solubilities as well as compounds characterized as having hydrophobic or hydrophilic characteristics.
Career Highlights
David M Oakley is associated with Aaipharma Services Corporation, where he applies his expertise in pharmaceutical development. His work focuses on creating innovative solutions that improve patient outcomes through effective drug delivery systems. Despite having no patents listed under his name, his contributions to the field are noteworthy.
Collaborations
David has collaborated with notable colleagues such as John R Cardinal and Jack Lawrence James. These partnerships have allowed him to enhance his research and development efforts in the pharmaceutical industry.
Conclusion
David M Oakley is a dedicated inventor whose work in extended-release pharmaceutical formulations showcases his commitment to advancing medical science. His innovative contributions continue to impact the field positively.